Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Evelo Biosciences, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 39 | 25 | −14 |
| SharesConverted for a 1-for-20 split | 4.29M | 3.60M | −683.8K (−16.0%) |
| Value | $15.5M | $11.3M | −$4.19M (−27.0%) |
New holders (1)
Institutions that held Evelo Biosciences, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Group One Trading, L.P. | 1,018 | $3.31K | 0.00% |
Sold out (15)
Institutions that held Evelo Biosciences, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| CVI Holdings, LLC | 840,577 | $151.9K |
| Susquehanna International Group, LLP | 184,104 | $33.3K |
| State Street Corp | 152,129 | $27.5K |
| Trustees of Columbia University in the City of New York | 113,850 | $20.6K |
| Bridgeway Capital Management, LLC | 105,300 | $19.0K |
| Northern Trust Corp | 94,330 | $17.0K |
| Jefferies Financial Group Inc. | 75,000 | $13.6K |
| Millennium Management LLC | 58,418 | $11.0K |
| Goldman Sachs Group Inc | 25,695 | $4.64K |
| Virtu Financial LLC | 24,337 | $4.00K |
| Avantax Planning Partners, Inc. | 15,000 | $2.71K |
| Bank of New York Mellon Corp | 13,150 | $2.38K |
| Affinity Capital Advisors, LLC | 10,595 | $1.92K |
| BNP Paribas Arbitrage, SA | 1,668 | $301 |
| National Bank of Canada | 100 | $18 |